Merck Gets PTAB To Nix Pfizer Vaccine Patent
The Patent Trial and Appeal Board on Wednesday invalidated every claim of a Pfizer patent tied to next generation pneumonia vaccines, handing a win to rival Merck Sharp & Dohme Corp.,...To view the full article, register now.
Already a subscriber? Click here to view full article